Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data

Affiliations

Quanfeng Zhao: Department of Pharmacy, The First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing, China
Pan Ma: Department of Pharmacy, The First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing, China
Peishu Fu: Department of Pharmacy, The First Affiliated Hospital of Third Military Medical University (Army Medical University), Chongqing, China
Jiayu Wang: Department of Pharmacy, Women and Children’s Hospital of Chongqing Medical University, Chongqing, China
Jiayu Wang: Department of Pharmacy, Chongqing Health Center for Women and Children, Chongqing, China
Kejing Wang: Department of Pharmacy, Women and Children’s Hospital of Chongqing Medical University, Chongqing, China
Kejing Wang: Department of Pharmacy, Chongqing Health Center for Women and Children, Chongqing, China
Lin Chen: Department of Pharmacy, Women and Children’s Hospital of Chongqing Medical University, Chongqing, China
Lin Chen: Department of Pharmacy, Chongqing Health Center for Women and Children, Chongqing, China
Yang Yang: Department of Pharmacy, Women and Children’s Hospital of Chongqing Medical University, Chongqing, China
Yang Yang: Department of Pharmacy, Chongqing Health Center for Women and Children, Chongqing, China

Abstract

No abstracts available.